g (36 ew i fe

THE ROCKEFELLER UNIVERSITY

1230 YORK AVENUE NEW YORK. NY 10021

November 28, 1979

 

JOSHUA LEDERBERG

PRESIDENT

Dr. J. Poirier

President

Institut de Recherches SERVIER
Science Union et Cie

14 rue du Val d'Or
92150-Suresnes

France

Dear Jean:

I was sorry to learn that Dr. Nathan had to withdraw
from the collaborative study on cyclomunine that had been
arranged between him and Dr: Leibowitch and yourself. I
am particularly sorry that the whole matter took so long
and especially when it had a fruitless outcome. There
were to begin with some technicalities, that derived from
the fact that his laboratory is also supported by the
National Institutes of Health, about which Dr. Nathan was
not well informed. The fact that you were so kind as to
send-me a copy of your communications enabled us to clear
up those problems, eventually; so I was sorry that it then
worked out that Dr. Nathan himself felt that he had to
withdraw. This is too bad since we are indeed eager to
see the ways in which we can be of help in industrial drug
development. Of course I was also most gratified to find
a way in which our own personal relationship might be aug-
mented by other activities of mutual advantage.

I hope that you will find other ways in which to pro-
ceed with the evaluation of cyclomunine and that it indeed
turns out to be a gratifying success for you. I have also
tried to educate our colleagues here about the most expedi-
tious procedures for entering into arrangements like this
so that, hopefully, we can avoid unnecessary delays in the
future.
Dr. J. Poirier
November 28, 1979

-2-

Above all I hope that this experience does not fore-
stall future attempts to find areas of convergent interests
and application and I remain,

Yours sincerely,

wy Masertr's
bel unser.
“sare ener
a) Dr. F. wt ty 67-4.

Mr. Rodney W. Nichols
Mr. David J. Lyons

Joshua derberg